Cite
Kang L, Voskinarian-Berse V, Law E, et al. Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy. Front Immunol. 2013;4:101doi: 10.3389/fimmu.2013.00101.
Kang, L., Voskinarian-Berse, V., Law, E., Reddin, T., Bhatia, M., Hariri, A., Ning, Y., Dong, D., Maguire, T., Yarmush, M., Hofgartner, W., Abbot, S., Zhang, X., & Hariri, R. (2013). Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy. Frontiers in immunology, 4101. https://doi.org/10.3389/fimmu.2013.00101
Kang, Lin, et al. "Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy." Frontiers in immunology vol. 4 (2013): 101. doi: https://doi.org/10.3389/fimmu.2013.00101
Kang L, Voskinarian-Berse V, Law E, Reddin T, Bhatia M, Hariri A, Ning Y, Dong D, Maguire T, Yarmush M, Hofgartner W, Abbot S, Zhang X, Hariri R. Characterization and ex vivo Expansion of Human Placenta-Derived Natural Killer Cells for Cancer Immunotherapy. Front Immunol. 2013 May 01;4:101. doi: 10.3389/fimmu.2013.00101. eCollection 2013. PMID: 23641243; PMCID: PMC3640206.
Copy
Download .nbib